1Jacobson, MD, Weil, M, Raff, MC. Programmed cell death in animal development. Cell 1997; 88: 347–54.
2Nagata, S. Apoptosis by death factor. Cell 1997; 88: 355–65.
3Iwasaki, K, Izawa, M, Mihara, M. DNA-damageinduced apoptosis in rat skin. J Dermatol Sci 1996; 12: 31–5.
4Iwasaki, K, Izawa, M, Mihara, M. Involvement of caspases in ultraviolet B-induced apoptosis in A431 human epitheloid tumor cells. Biochem Mol Biollnt. 1997; in press.
5Suda, T, Takahashi, T, Golstein, P, Nagata, S. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169–78.
6Tanaka, M, Suda, T, Haze, K et al. Fas ligand in human serum. Nature Med 1996; 2: 317–22.
7Nagata, S, Golstein, P. The Fas death factor. Science 1995; 267: 1449–56.
8Itoh, N, Yonehara, S, Ishii, A et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233–43.
9Vandenabeele, P, Declerq, W, Beyaert, R, Fiers, W. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol 1995; 5: 392–9.
10Chinnaiyan, AM, O'Rourke, K, Yu, GL et al. Signal transduction by DR-3, a death domaincontaining receptor related to TNFR-1 and CD95. Science 1996; 274: 990–2.
11Kiston, J, Raven, T, Jiang, YP et al. A deathdomain-containing receptor that mediates apoptosis. Nature 1996; 384: 372–75.
12Brojatsch, J, Naughton, J, Rolls, MM, Zingler, K, Young, JAT. CAR 1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosissarcoma viruses and mediate apoptosis. Cell 1996; 87: 845–55.
13Enari, M, Hase, A, Nagata, S. Apoptosis by a cytosolic extract from Fas-activated cells. EMBO J 1995; 14: 5201–8.
14Enari, M, Talanian, RV, Wong, WW, Nagata, S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 1996; 380: 723–6.
15Izawa, M, Kato, Y, Iwasaki, K. Induction of a receptor-mediated genomic DNA fragmentation in rat thymus following administration of glucocorticoids with different biopotencies: an approach by cell-free system. Endocr J 1997; in press.
16Kuida, K, Lippke, JA, Ku, G et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 1995; 267: 2000–3.
17Kuida, K, Zheng, TS, Na, SQ et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384: 368–72.
18Veis, DJ, Sorenson, CM, Shutter, JR, Korsmeyer, SJ. Bcl-2-deficient mice demonstrate fulminent lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993 75: 229–40.
19Shimizu, S, Eguchi, Y, Kamiike, W, Matsuda, H, Tsujimoto, Y. Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene 1996; 12: 2251–7.
20Chinnaiyan, AM, Orth, K, O'Rourke, K, Duan, H, Poirier, GG, Dixit, VM. Molecular ordering of the cell death pathway. J Biol Chem 1996; 271: 4543–76.
21Steller, H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445–9.
22White, E. Life, death, and the pursuit of apoptosis. Genes Dev 1996; 10: 1–15.
23Milligan, CE, Prevette, D, Yaginuma, H et al. Peptide inhibitors for the ICE protease family arrest programmed cell death of mononeurons in vivo and in vitro. Neuron 1995; 15: 385–93.
24Jacobson, MD, Weil, M, Raff, MC. Role of CED-3/ICE family proteases in staurosporine-induced programmed cell death. J Cell Biol 1996; 133: 1041–51.
25Coucouvanis, E, Martin, GR. Signals for death and survival: a two-step mechanism for cavitation in the vertebrate embryo. Cell 1995; 83: 279–84.
26El Shershaby, AM, Hinchlitte, JR. Cell redundancy in the zona-intact preimplantation mouse blastocyst: a light and electron microscope study of dead cells and their fate. J Embryol Exp Morphol 1974 31: 643–54.
27Allan, DJ, Harmon, BU, Kerr, JFR. Cell death in spermatogenesis. In: Potten, CS ed. Perspectives on mammalian cell death. London: Oxford Press, 1987; 229–58.
28Thiet, MP, Suwanvanichkij, V, Kwok, C, Yeh, J. DAN laddering, consistent with programmed cell death, is a normal finding in human placentas. Am J Obstet Gynecol 1995; 172: 272.
29Nelson, DM. Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta 1996; 17: 387–91.
30Yasuda, M, Umemura, S, Osamura, RY, Kenjo, T, Tsutsumi, Y. Apoptotic cells in human endometrium and placental villi: pitfalls in applying the TUNEL method. Arch Histol Cytol 1995; 58: 185–90.
31O'Shea, JD, Hay, MF, Cran, DG. Ultrastructural changes in the theca interna during follicular atresia in sheep. J Reprod Fertil 1978; 54: 183–7.
32O'Shea, JD, Nightingale, MG, Chamley, WA. Changes in small blood vessels during cyclical luteal regression in sheep. Biol Reprod 1977; 17: 162–77.
33Kerr, JF, Wyllie, AH, Currie, AR. Apoptosis: a basic biochemical phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–57.
34Hurwitz, A, Adashi, EY. Ovarian follicular atresia as an apoptotic process: a paradigm for programmed cell death in endocrine tissues. Mol Cell Endocrinol 1992; 84: C19–C23.
35Tilly, JL, Kowalski, KI, Johnson, AL, Hsueh, AJ. Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology 1991; 129: 2799–801.
36Palumbo, A, Yeh, J. In situ localization of apoptosis in the rat ovary during follicular atresia. Biol Reprod 1994; 51: 888–95.
37Yeh, J, Lin, MC, Hasselblatt, K. Concurrent expression of fas and bcl-2 mRNA in hyperandrogenized rat granulosa cells. Mol Biol Cell 1994; 5: 95a.
38Tilly, JL, Tilly, KI, Kenton, ML, Johnson, AL. Expression of members of the bcl-2 gene family in the immature rat ovary: equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is a ssociated with decreased bax and constitutive bcl-2 and bcl-Xionß messenger ribonucleic aid levels. Endocrinology 1995; 136: 232–41.
39Guo, MW, Mori, E, Xu, JP, Mori, T. Identification of Fas antigen associated with apoptotic cell death in murine ovary. Biochem Biophys Res Commun 1994; 203: 1438–46.
40Quirk, SM, Cowan, RG, Joshi, SG, Henrikson, KP. Fas antigen-mediated apoptosis in human granulosa/luteal cells. Biol Reprod 1995; 52: 279–87.
41Sanders, SL, Kaynard, AH, Melner, MH. Localization and expression of sulfated glycoprotein-2(SGP-2) mRNA in the rat ovary. [Abstract 1632]. Proceedings of the 75th Meeting of The Endocrine Society 1993.
42Lee, BS, Robinson, RD, Best, CL, Hill, JA, Yeh, J. Expression of apoptosis related genes, bcl-2 and TRP M-2, in human lutenized granulosa cells [Abstract]. J Soc Gynecol Invest 1995; 2: 389.
43Kondo, H, Maruo, T, Peng, X, Mochizuki, M. Immunological evidence for the expression of the Fas antigen in the infant and adult human ovary during follicular regression and atresia. J Clin Endocrinol Metab 1996; 81: 2702–10.
44Li, S, Maruo, T, Ladin-Llabe, CA, Kondo, H, Mochizuki, M. Stage-limited expression of myc oncoprotein in human ovary during follicular growth, regression and atresia. Endocrin J 1994; 41: 83–92.
45Yeh, J, Osathanondh, R, Villa-Komaroff, L. Expression of messenger ribonucleic acid for epidermal growth factor and its ligands, epidermal growth factor and transforming growth factoralpha, in human first- and second-trimester fetal ovary and uterus. Am J Obstet Gynecol 1993; 168: 1569–73.
46Yeh, J, Osathanondh, R. Expression of messenger ribonucleic acids encoding for basic fibroblast growth factor (FGF) and alternatively spliced FGF receptor in human fetal ovary and uterus. J Clin Endocrinol Metab 1993; 77: 1367–71.
47Schilling, B, Yeh, J. Messenger RNA and protein expression of transforming growth factor (TGF) β1, β2, β3 and their receptors (R1.R2) in human fetal oogenesis [Abstract O-014]. 62nd Annual Meeting of American Society for Reproductive Medicine, Boston, Mass., 2–6 11, 1996.
48Bennett, RA, Osathanondh, R, Yeh, J. Immunohistochemical localization of transforming growth factor-α, epidermal growth factor and EGF receptor in the human fetal ovary. J Clin Endocrinol Metab 1996; 81: 3073–6.
49Bennett, RA, Osthanondh, R, Yeh, J. Programmed cell death in second-trimester human fetal ovaries [Abstract P-156]. 51st Annual Meeting of American Society for Reproductive Medicine, Seatle, Wash., 7–12 10 1995.
50Oberhammer, FA, Pavelka, M, Sharma, S et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor p 1. Proc Natl Acad Sci USA 1992; 89: 5408–12.
51Schulze-Osthoff, K, Walczak, H, Droge, W, Krammer, H. Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 1994; 127: 15–20.
52Jacobson, MD, Burne, J, Raff, MC. Programmed cell death and bcl-2 protein in the absence of a nucleus. EMBO J 1994; 13: 1899–910.
53Palumbo, A, Yeh, J. In situ identification of apoptosis in a rat model of polycystic ovarian disease [Abstract 073]. Proceedings of the 41st Meeting of the Society for Gynecologic Investigation, Chicago, Ill., 22–24 03 1994.
54Stein, IF, Leventhal, ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181–91.
55Almahbobi, G, Anderiesz, C, Hutchinson, P, McFarlane, JR, Wood, C, Trouson, AO. Functional integrity of granulosa cells from polycystic ovaries. Clin Endocrinol 1996; 44: 571–80.
56Yeh, J, Kim, HH. Polycystic Ovary Syndrome (PCOS): the possible roles of apoptosis in human granulosa cells. In: Chang, RJ ed. Polycystic ovary syndrome (Serono Symposia), New York: Springer-Verlag, 1996: 51–70.
57Palumbo, A, Yeh, J. Apoptosis as a basic mechanism in the ovarian cycle: follicular atresia and luteal regression. J Soc Gynecol Invest 1995; 2: 565–73.
58Lee, BS, Yeh, J. The molecular basis of follicular atresia: apoptosis as a possible mechanism. Adv Contracep Dev Sys 1996; 12: 269–82.
59Sheets, EE, Yeh, J. The role of apoptosis in gynecologic malignancies. Ann Med 1997; in press.
60Sheets, EE, Crum, CP, Yeh, J. Association between cervical neoplasia and apoptosis as detected by in situ nuclear labeling. Gynecol Oncol 1996; 63: 94–100.
61Sheets, EE, McGahan, C, Crum, CP, Yeh, J. Genetic control of apoptosis during cervical neoplasia. Gynecol Oncol 1996; 62: 417.
62Shoji, Y, Saegusa, M, Takano, Y, Ohbu, M, Okayasu, I. Correlation of apoptosis with tumor cell differentiation, progression, and HPV infection in cervical carcinoma. J Clin Pathol 1996; 49: 134–38.
63Isacson, C, Kessis, TD, Hedrick, L, Cho, KR. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus. Cancer Res 1996; 56: 669–74.
64Garzetti, GG, Ciavattini, A, Provinciali, M et al. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy. Anticancer Res 1996; 16: 3229–34.
65Levin, EL, Renehan, A, Gossiel, R et al. Apoptosis, intrinsic readiosensitivity and prediction of radiotherapy. Radiother Oncol 1995; 37: 1–9.
66Hughes, DE, Dai, A, Triffee, JC, Li, HH, Mundy, GR, Boyce, BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med 1996;2: 1132–36.
67Isaacs, JT. Antagonistic effect of androgen on prostatic cell death. Prostate 1984; 5: 545–57.
68Kerr, JFR, Searle, J. Deletion of cells by apoptosis during castration-induced involution of the rat prostate. Virchows Arch B 1973; 13: 87–102.
69Kyprianou, N, Isaacs, JT. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 1988; 122: 552–62.
70English, HF, Kyprianou, N, Isaacs, JT. Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration. Prostate 1989; 15: 233–50.
71Izawa, M. Expression of sulfated glycoprotein, 2 and pSvr-1 genes and involution of steroid hormone-dependent rat tissues. Endocrinol Jpn 1991; 38: 61–6.
72Montpetit, ML, Lawless, KR, Tenniswood, M. Androgen repressed messages in the rat ventral prostate. Prostate 1986; 8: 25–36.
73Buttyan, R, Olsson, CA, Pinter, J et al. Induction of the TRPM-2 gene in cells undergoing programmed cell death. Mol Cell Biol 1989; 9: 3473–81.
74Kyprianou, N, Isaacs, JT. Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 1989 3: 1515–22.
75Buttyan, R, Zakeri, Z, Lockshin, R, Wolgemuth, P. C ascade induction of c-fos, c-myc, and heat shock 70 k transcripts during regression of the rat ventral prostate gland. Mol Endocrinol 1988; 2: 650–57.
76Quarmby, VE, Beckman, WC Jr, Wilson, EM, French, FS. Androgen regulation of c-myc messenger ribonucleic acid levels in rat ventral prostate. Mol Endocrinol 1987; 1: 856–74.
77Izawa, M. Molecular cloning and sequencing of rat Max cDNA: castration-induced expression of the 2kb transcript in male accessory sex organs of rats. Biochim Biophys Acta 1993; 1261: 492–4.
78Suzuki, A, Matsuzawa, A, Iguchi, T. Down regulation of Bcl-2 is the first step on Fasmediated apoptosis of male reproductive tract. Oncogene 1996; 13: 31–7.
79Izawa, M, Kimura, M, Saji, M. Castration-induced expression of ICE (interleukin -1β converting enzyme) in male accessory sex organs of rats. The Proceeding of Annual Meeting of Japan Society of Andrology. Workshop on Apoptosis, Kurashiki, Japan, 07 19–20, 1996.
80Izawa, M. Identification of a transcript predicting an alternative form of sulfated glycoprotein- 2(clusterin) in rat tissues. Biochem Mol Biol Int 1997; in press.
81Berges, R, Furuya, Y, Remington, L, English, HF, Jacks, T, Isaacs, JT. Cell proliferation, DNA repair, and p53 function are not required for programmed cell death of prostatic glandular cells induced by androgen ablation. Proc Natl Acad Sci USA 1994; 90: 8910–14.
82Furuya, Y, Lin, XS, Walsh, JC, Nelson, WG, Isaacs, JT. Androgen ablation-induced programmed cell death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction. Endocrinology 1995; 136: 1898–906.
83Bianco-Rodriguez, J, Martinez-Garcia, C. Spontaneous germ cell death in the testis of the adult rat takes the form of apoptosis: reevaluation of cell types that exhibit the ability to die during spermatogenesis. Cell Prolif 1996; 29: 13–31.
84Shetty, J, Marathe, GK, Dighe, RR. Specific immunoneutralization of FSH leads to apoptotic cell death of the pachytene spermatocytes and spermatogonical cells in the rat. Endocrinology 1996; 137: 2179–82.
85Blanco-Rodrigez, J, Martinez-Garcia, C. Induction of apoptotic cell death in the seminiferous tubule of the adult rat testis: assessment of the germ cell types that exhibit the ability to enter apoptosis after hormone suppression by oestradiol. Int J Androl 1996; 19: 237–47.
86Shikone, T, Billing, H, Hsueh, AJ. Experimentally induced cryptorchidism increases apoptosis in rat testis. Biol Reprod 1995; 51: 865–72.
87Kyprianou, N, English, HF, Isaacs, JY. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 1990; 50: 3748–53.
88Rittmaster, RS, Norman, RW, Thomas, LN, Rowden, G. Evidence for atrophy and apoptosis in the prostates of men given finasteride. J Clin Endocrinal Metab 1996; 81: 814–819.
89Bauer, JJ, Sesterhenn, IA, Mostofi, FK, McLeod, DG, Srivastava, S, Moul, JW. Elevated levels of apoptosis regulator protins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer. J Urol 1996; 156: 1511–16.
90Magi-Galluzzi, C, Mishra, R, Fiorentino, M et al. Mitogen-activated protein kinase phophatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Lab Invest 1997; 76: 35–51.
91Heiskanen, P, Billig, H, Toppari, J et al. Apoptotic cell death in the normal and cryptorchid human testis: the effect of human chorionic gonadotropin on testicular cell survival. Pediatr Res 1996; 40: 351–56.
92Smith, CA, Williams, GT, Kingston, R, Jenkinson, EJ, Owen, JJ. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 1989; 337: 181–4.
93Benhamou, LE, Cazenave, PA, Sarthou, P. Antiimmunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells. Eur J Immunol 1990; 20: 1405–7.
94Sheiness, D, Bishop, JM. DNA and RNA from uninfected vertebrate cells contain nucleotide sequences related to the putative transforming gene of avian myelocytomatosis virus. J Virol 1979; 31: 514–21.
95Lee, SY, Sugiyama, A, Sueoka, N, Kuchino, Y. Point mutation of the neu gene in rat neural tumor RT4-AC cells: suppression of tumorigenicity by s-MYC. Jpn J Cancer Res 1990; 81: 1085–8.
96Yonshi-Rouach, E, Resnitzky, D, Lotem, J, Sachs, L, Kimchi, A, Oren, M. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 1991; 352: 345–47.
97Woronicz, JD, Calnan, B, Ngo, V, Winoto, A. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 1994; 367: 277–81.
98Matsuzaki, Y, Fujisawa, J, Yoshida, M. Identification of transcriptional activation domain of TREB5, a CREB/ATF family protein that binds to HTLV-1 enhancer. J Biochem (Tokyo) 1995; 117: 303–8.
99Shi, L, Nishioka, WK, Th'ng, J, Brasbury, EM, Litchfield, DW, Greenberg, AH. Premature p34cdc2 activation required for apoptosis. Science 1994; 263: 1143–5.
100Montague, JW, Gaido, ML, Frye, C, Cidlowski, JA. A calcium-dependent nuclease from apoptotic rat thymocytes is homologous with cyclophilin. Recombinant cyclophilins A, B, and C have nuclease activity. J Biol Chem 1994; 269: 18877–80.
101Packham, G, Cleveland, JL. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol Cell Biol 1994; 14: 5741–7.
102Melino, G, Annicchiarico-Petruzzelli, M, Piredda, L et al. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol Cell Biol 1994; 14: 6584–96.
103Koh, JY, Yang, LL, Cotman, CW. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 1990; 533: 315–20.
104Shi, L, Kraut, RP, Aebersold, R, Greenberg, AH. A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med 1992; 175: 553–66.
105Berke, G. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Ann Rev Immunol 1994; 12: 753–73.
106Yang, E, Zha, J, Jockel, J, Boise, LH, Thompson, CB, Korsmeyer, SJ. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80: 285–91.
107Takayama, S, Sato, T, Krajewski, S et al. Cloning and functional analysis of BAG-1: a novel Bcl-2- binding protein with anti-cell death activity. Cell 1995; 80: 279–84.
108Boyd, JM, Gallo, GJ, Elangovan, B et al. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survivalpromoting proteins. Oncogene 1995; 11: 1921–8.
109Chittenden, T, Harrington, EA, O'Conner, R et al. Induction of apoptosis by Bcl-2 homolog Bak. Nature 1995; 374: 733–6.
110Kiefer, MC, Brauer, MJ, Powers, VC et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 1995; 374: 736–9.
111Boyd, JM, Malstrom, S, Subramanian, T et al. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 1994; 79: 341–51.
112Lin, EY, Orlofsky, A, Berger, MS, Prystowsky, MB. Characterization of Al, a novel hemopoieticspecific early-response gene with sequence similarity to bcl-2. J Immunol 1993; 151: 1978–88.
113Kozopas, KM, Yang, T, Buchan, HL, Zhou, P, Craig, RW. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA 1993; 90: 3516–20.
114Opipari, AW Jr, Hu, HM, Yabkowitz, R, Dixit, VM. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 1992; 267: 12424–7.
115Sugawara, S, Takeda, K, Lee, A, Dennert, G. Suppression of stress protein GRP78 induction in tumor B/C10ME eliminates resistance to cell mediated cytotoxicity. Cancer Res 1993; 53: 6001–5.
116Nakashima, T, Sekiguchi, T, Kuraoka, A et al. Molecular cloning of a human cDNA encoding a novel protein, DAD1, whose defect causes apoptotic cell death in hamster BHK21 cells. Mol Cell Biol 1993; 13: 6367–74.
117Fath, I, Schweighoffer, F, Rey, I et al. Cloning of a Grb2 isoform with apoptotic properties. Science 1994; 264: 971–4.
118Wong, GH, Elwell, JH, Oberley, LW, Goeddel, DV. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989; 58: 923–31.
119Rosen, DR, Siddique, T, Patterson, D et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59–62.
120Hockenbery, DM, Oltvai, ZN, Yin, XM, Milliam, CL, Korsmeyer, SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75: 241–51.
121Ishida, Y, Agata, Y, Shibahara, K, Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 1992; 11: 3887–95.
122Owens, GP, Hahn, WE, Cohen, JJ. Identification of mRNA associated with programmed cell death in immature thymocytes. Mol Cell Biol 1991; 11: 77–88.
123Dowd, DR, MacDonald, PN, Komm, BS, Haussler, MR, Miesfeld, R. Evidence for early induction of calmodulin in gene expression in lymphocytes undergoing glucocorticoid-mediated apoptosis. J Biol Chem 1991; 266: 18423–6.
124Alnemri, ES, Livingston, DJ, Niclholson, DW et al. Human ICE/CED-3 protease nomenclature. Cell 1996; 87: 171.